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ABSTRACT
Children with calcium-deficiency rickets may have increased vitamin D requirements and respond differently to vitamin D2 and
vitamin D3. Our objective was tocomparethe metabolism ofvitamins D2andD3inrachitic and control children. Weadministered anoral
single dose of vitamin D2 or D3 of 1.25mg to 49 Nigerian children—28 with active rickets and 21 healthy controls. The primary outcome
measure was the incremental change in vitamin D metabolites. Baseline serum 25-hydroxyvitamin D [25(OH)D] concentrations ranged
from 7 to 24 and 15 to 34ng/mL in rachitic and control children, respectively (p<.001), whereas baseline 1,25-dihydroxyvitamin
D [1,25(OH)2D] values (mean SD) were 224 72 and 121 34pg/mL, respectively (p<.001), and baseline 24,25-dihydroxyvitamin
D[24,25(OH)2D]valueswere1.13 0.59and4.03 1.33ng/mL,respectively(p<.001).Thepeakincrementin25(OH)Dwasonday3and
wassimilarwithvitaminsD2andD3inchildrenwithrickets(29 17and25 11ng/mL,respectively)andincontrolchildren(33 13and
31 16ng/mL, respectively). 1,25(OH)2D rose significantly (p<.001) and similarly (p¼.18) on day 3 by 166 80 and 209 83pg/mL
after vitamin D2 and D3 administration, respectively, in children with rickets. By contrast, control children had no significant increase in
1,25(OH)2D (19 28 and 16 38pg/mL after vitamin D2 and D3 administration, respectively). We conclude that in the short term,
vitamins D2 and D3 similarly increase serum 25(OH)D concentrations in rachitic and healthy children. A marked increase in 1,25(OH)2Di n
response to vitamin D distinguishes children with putative dietary calcium-deficiency rickets from healthy children, consistent with
increased vitamin D requirements in children with calcium-deficiency rickets.  2010 American Society for Bone and Mineral Research.
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Introduction
C
lassically, vitamin D deficiency is distinguished from vitamin
D insufficiency by the presence of marked biochemical
perturbations in mineral metabolism and clinical and/or
radiologic features of rickets or osteomalacia, although the
severity of the signs and biochemical abnormalities do depend
on the duration of the deficiency. Vitamin D–deficiency rickets is
characterizedbylowcirculatinglevels(typically<5ng/mL)of25-
hydroxyvitamin D [25(OH)D], impaired intestinal calcium
absorption,secondaryhyperparathyroidism,andanexaggerated
increase in serum 1,25-dihydroxyvitamin D [1,25(OH)2D] con-
centration after administration of vitamin D.
(1–4) Although,
worldwide, vitamin D deficiency is the principal cause of rickets,
in some countries, such as Nigeria and Bangladesh, nutritional
rickets results primarily from inadequate calcium intake.
(5,6)
Untreated Nigerian children with nutritional rickets have normal
or only slightly reduced 25(OH)D values,
(7) high fractional
calcium absorption,
(8) low dietary calcium intake,
(7) markedly
elevated 1,25(OH)2D concentrations, and a better response to
treatment with calcium than with vitamin D.
(9) These findings
indicate that dietary calcium deficiency plays a more important
role in the pathogenesis of rickets in Nigerian children than does
vitamin D deficiency.
Operationally,vitaminDsufficiency representsastateinwhich
the serum concentration of 1,25(OH)2D will not increase further
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1988after raising the concentration of 25(OH)D. Under these
conditions, serum levels of substrate 25(OH)D are adequate to
maintain the required 1,25(OH)2D concentrations.
(10,11) More-
over, the concentration of 25(OH)D necessary to ensure normal
mineral homeostasis will depend on the usual intake of dietary
calcium. Not surprisingly, Nigerian children with rickets owing to
dietary calcium deficiency have evidence for an increased
requirement for vitamin D to optimize mineral metabolism.
(12)
Dietary calcium deficiency leads to secondary hyperparathyroid-
ism, which decreases serum levels of 25(OH)D both directly,
through increased conversion to 1,25(OH)2D, and indirectly, via
enhanced degradation of 25(OH)D by the 24-hydroxylase
enzyme CYP24A1, which is induced by 1,25(OH)2D.
(13,14)
Administration of vitamin D2 to Nigerian children with rickets
produces a nearly twofold increase in 1,25(OH)2D concentra-
tions, even though 1,25(OH)2D concentrations are markedly
elevated prior to vitamin D administration. The increase in
1,25(OH)2D concentrations is similar to the response of children
with vitamin D–deficiency rickets (although their baseline values
are usually lower), consistent with the presence of secondary
hyperparathyroidism and suggesting that vitamin D require-
ments are increased in calcium-deficiency rickets.
(12) Conse-
quently, we hypothesize that vitamin D requirements are
increased by dietary calcium deficiency, but whether the low
vitamin D status contributes to the pathogenesis of rickets in
Nigerian children is currently unknown.
Vitamin D3 is the endogenous form of vitamin D produced by
keratinocytes in the skin in response to ultraviolet B radiation
from sunlight. Vitamin D2 is produced by irradiation of plant
ergosterol and is used commonly for supplementation and food
fortification. Both forms of vitamin D are hydroxylated inthe liver
to 25(OH)D. It has been suggested that vitamin D3 may be
superior to vitamin D2 in sustaining adequate 25(OH)D values in
adults
(15,16) because 25(OH)D2 may bind less avidly to vitamin D–
binding protein and be cleared more rapidly than 25(OH)D3.
However, others have found that regular supplementation with
both forms of vitamin D were equally effective in maintaining
25(OH)D levels.
(17,18) The aim of this study was to compare the
short-term metabolism of vitamin D2 with that of vitamin D3 in
children with rickets and in healthy control children without
rickets.
Materials and Methods
We recruited children with genu varus or valgus deformities
characteristic of rickets from the outpatient department of the
Jos University Teaching Hospital in Nigeria. Radiographs of the
wrists and knees were obtained. Those with active rickets,
defined as a radiographic score of 1.5 or greater on a 10-point
scale of severity,
(19) were invited to participate in the study.
Approval for the study was obtained from the Ethical Committee
of the Jos University Teaching Hospital and the Institutional
Review Board of the Mayo Clinic, and written informed consent
was obtained from a parent of each enrolled child.
Healthy control children were recruited by asking each parent
of a child with rickets to invite a child without clinical evidence of
rickets of the same age and gender, who was a neighbor or
relative, to participate. In cases where a neighbor or relative
control was unable to be recruited, control children were
recruited among the staff of the outpatient department.
Transportation costs were paid for all enrolled children, and a
gift valued at approximately $10 was provided to each enrolled
child. Children with rickets were provided with 6 months of
treatment with calcium and vitamin D at no cost after
completing the 2-week study. Calcium was withheld during
the study to avoid confounding the relationships between
biochemical variables, allowing all changes to be attributed to
the effect of vitamin D.
Data were collected from all children regarding usual sunlight
exposureandthefrequencyandquantityofdairyproductintake.
The percentage of unclothed skin at enrollment was estimated
by using a Lund and Browder age-related burn chart. Control
children were randomly assigned by lottery to receive either
vitamin D3 (cholecalciferol; Bio-Tech, Fayetteville, AR, USA) or
vitamin D2 (ergocalciferol; Pliva, Inc., East Hanover, NJ, USA) as a
single oral dose of 1.25mg (50,000 IU). Although the potency of
each form of vitamin D was identical, the matrix materials were
notidentical forthe twoproducts. Venous bloodwascollected at
baselineandat1,3,7,and14daysafteradministrationofvitamin
D. All rachitic children in this study were given a single dose of
vitamin D3 because the data on the metabolism of vitamin D2 in
rickets were obtained from a previous study of 16 Nigerian
children with rickets using vitamin D2 with an identical study
protocol and laboratory.
(12)
Serum samples were transported frozen to the Mayo Clinic for
analysis. Serum calcium, phosphorus, alkaline phosphatase, and
albumin were measured by standard methods. We measured all
vitamin D metabolites by isotope-dilution liquid chromatogra-
phy–tandem mass spectrometry (LC-MS/MS).
(20) Unless other-
wise indicated by subscript notation for individual metabolites,
25(OH)D, 24,25(OH)2D, and 1,25(OH)2D refer to the total
concentrations of the D2 and D3 forms of each metabolite.
In the subgroup of children with rickets in the previous study
that received vitamin D2, 25(OH)D and 1,25(OH)2D concentra-
tions had been determined in the same laboratory by RIA
(DiaSorin, Stillwater, MN, USA). Stored sera were available for 33
of the original 80 samples from children with rickets who had
been given vitamin D2 and had vitamin D metabolites measured
by RIA. In order to assess the agreement between values
obtained by RIA and MS, we measured 25(OH)D and 1,25(OH)2D
concentrations in these 33 samples with the MS methodology
used in this study. Values obtained by MS and RIA were highly
correlated for both 25(OH)D (r¼0.90, slope¼0.94 for MS as a
function of RIA with intercept set at 0) and 1,25(OH)2D( r¼0.92,
slope¼1.35), indicating that both methods gave similar values.
Data analysis and anthropometric calculations were per-
formed with Epi Info 3.5.1 (CDC, Atlanta, GA, USA) and Excel 2003
(Microsoft Corp., Redmond, WA, USA). Nutritional anthropo-
metric variables were calculated with the Nutrition program of
Epi Info with Centers for Disease Control and Prevention (CDC)/
World Health Organization (WHO) 1978 reference growth curves.
A paired t test was used to compare values of continuous
normally distributed variables with baseline values, and an
unpaired t test was used to compare values of continuous
variables between groups. A linear regression analysis was used
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14 between the vitamin D2 and vitamin D3 groups while
controlling for peak 25(OH)D concentration on day 3 as a
covariate. p values less than .05 were considered significant.
Results
A total of 46 children with lower extremity deformities were
screened, and 13 children (4 males, 9 females) with radiographic
evidence of rickets were recruited to receive vitamin D3. One
child with rickets who received vitamin D3 was excluded from
analysis because her response was an extreme outlier (described
below). A total of 23 control children were recruited. One control
child who received vitamin D3 did not return after the baseline
visit and was excluded from the analysis. A second control child
who failed to demonstrate an increase in serum concentration of
25(OH)D after administration of vitamin D2 was excluded from
analysis because of doubts that he actually ingested the dose of
vitamin D2. Data from 16 previously studied children with active
rickets who had received vitamin D2 using the same protocol
were included in the analysis.
Baseline characteristics of enrolled children are shown in
Table 1. Baseline serum levels of 25(OH)D, 1,25(OH)2D, and
24,25(OH)2D differed significantly between rachitic and control
children (p<0.001). Among rachitic children, age, radiographic
scores, and most biochemical values differed significantly
(p<.01) between the vitamin D2 and vitamin D3 groups,
consistent with more severe rickets in the group that received
vitaminD2.However,theserumcalciumconcentrationwaslower
in the vitamin D3 group than in the vitamin D2 group (p¼.003).
None ofthe children withrickets hadseverevitamin Ddeficiency
[serum concentration of 25(OH)D<5ng/ml]. Owing to their
lower extremity deformities, children with rickets had reduced
height for age, but they did not differ in weight for height from
control children. Calcium intakes derived from dairy products
were low in all groups and significantly lower in children with
active rickets than in control children (p¼.002).
Serum levels of vitamins D2 and D3 were measured in control
children, and neither was detectable at baseline. One day after
vitamin D administration, serum vitamin D2 was 88.4 27.2ng/
mL in the vitamin D2 group, and serum vitamin D3 was
148.9 47.6ng/mL in the vitamin D3 group of control children
(p¼.002).
Table 1. Baseline Characteristics of Nigerian Children With Nutritional Rickets and Healthy Control Children
a
Characteristic
Rachitic children Control children
Reference
range
Vitamin D2
(n¼16)
Vitamin D3
(n¼12)
Vitamin D2
(n¼11)
Vitamin D3
(n¼10)
Age (months) 31 (15–48)
b 71 (23–120) 39 (22–57) 31 (19–59)
Sex (M:F) 9:7 4:8 5:6 5:5
Duration of symptoms (months) 14 (0.1–34)
b 41 (5–102)
Radiographic score 4.0 (2.0–10.0)
b 1.6 (1.5–7.0) 0 (normal XR)
Exposure to sunlight (h/day) 0.9 (0–12) 3.8 (0.5–5) 5.0 (0.5–10) 5.0 (2–6)
Exposed skin (%) 47 (43–57) 50 (43–57) 47 (43–57) 43 (43–53)
Dairy product calcium intake
(mg/day)
31 (0–71) 15 (0–271) 71 (0–522) 115 (0–613)
Height for age Z-score  3.4 ( 5.7 to  1.5)  3.8 ( 5.5 to  0.3) 0.7 ( 0.9 to 2.9)  0.4 ( 1.9 to 2.3)  2.0 to 2.0
Weight for height Z-score  0.7 ( 2.7 to 1.9)
b 0.4 ( 1.6 to 1.9)  0.4 ( 2.0 to 0.9)  0.2 ( 2.0 to 1.0)  2.0 to 2.0
Serum biochemistry
Calcium (mg/dL)
c 9.4 (7.7–10.0)
b 7.9 (6.1–9.1) 9.3 (8.7–10.3) 9.8 (8.6–10.4) 9.6–10.6
Phosphorus (mg/dL)
d 3.5 (2.1–4.4) 4.1 (2.8–6.6) 4.7 (4.2–5.5) 5.1 (4.4–6.5) 3.7–5.4
Alkaline phosphatase (U/L) 732 (451–1268)
b 412 (275–1552) 167 (89–196) 178 (105–230) 149–476
Albumin (g/L) 43 (39–46) 39 (31–45) 43 (38–47) 42 (35–46) 35–50
25(OH)D (ng/mL)
e 11 (7–16)
b 15 (11–24) 26 (21–34) 28 (15–33) 25–80
f
1,25(OH)2D (pg/mL)
g 175 (120–330)
b 271 (166–390) 101 (90–178) 125 (72–208) 24–86
24,25(OH)2D (ng/mL)
h 0.98
i (0.33–1.7) 0.90 (0.43–2.8) 4.11 (2.39–5.84) 4.27 (1.44–5.94) Not established
24,25(OH)2D/25(OH)D
proportion (%)
10 (5–13) 7 (4–16) 16 (9–23) 14 (10–33) Not established
aData are shown as median values (range).
bp<.01 for comparison with the vitamin D3 group.
cTo convert values for calcium to millimoles per liter, multiply by 0.25.
dTo convert values for phosphorus to millimoles per liter, multiply by 0.32.
eTo convert values for 25(OH)D to nanomoles per liter, multiply by 2.50.
fOptimal range.
gTo convert values for 1,25(OH)2D to picomoles per liter, multiply by 2.40.
hTo convert values for 24,25(OH)2D to nanomoles per liter, multiply by 2.40.
in¼10.
1990 Journal of Bone and Mineral Research THACHER ET AL.Total 25(OH)D concentrations peaked on day 3 (Fig. 1), and
incremental changes were similar in the rachitic children who
received vitamin D2 or vitamin D3 (29 17 and 25 11ng/mL,
respectively) and in control children after vitamin D2 or vitamin
D3 administration (33 13 and 31 16ng/mL, respectively).
These data suggest that the bioavailability of both forms of
vitamin D was similar despite differences in the matrices of the
two preparations and greater levels of serum vitamin D2 on day
1. The day 3 concentration of total 25(OH)D was less than 30ng/
mL in 6 (21%) of the children with rickets and in none of the
control children. The highest values of 25(OH)D, attained on day
3, were 77 and 101ng/mL in rachitic and control children,
respectively. The disappearance rate of total 25(OH)D after day 3
was similar after vitamin D2 and vitamin D3 administration in
control children, suggesting that under conditions of normal
mineral homeostasis, these two forms of vitamin D are
bioequivalent. In a linear regression analysis controlling for
the 25(OH)D concentration on day 3 as a covariate, there was a
greater decline in 25(OH)D concentrations on day 7 (p<.001)
and on day 14 (p<.001) in the vitamin D2 group than the
vitamin D3 group among children with rickets, consistent with a
more rapid clearance of 25(OH)D2 than 25(OH)D3. Although the
group that received vitamin D2 had lower baseline 25(OH)D
values than the vitamin D3 group, both groups achieved similar
peak levels of 25(OH)D on day 3.
Figure 2 depicts the decline in endogenous 25(OH)D3
concentrations following the administration of vitamin D2 to
rachitic and control children. Endogenous 25(OH)D3 concentra-
tions declined gradually in both rachitic and control children,
reaching 53% and 59% of baseline values by day 14.
Figure 3 shows the response of 1,25(OH)2D concentrations to
vitamin D administration. The significant increase (p<.001) in
1,25(OH)2D concentrations from baseline to day 3 was similar for
both forms of vitamin D in rachitic children (166 80 and
209 83pg/mL after vitamin D2 and vitamin D3 administration,
respectively; p¼.18). In the children with rickets, 1,25(OH)2D
concentrations nearly doubled in response to both vitamin D2
and vitamin D3. Moreover, in the two groups of children with
rickets, the rates of decline of 1,25(OH)2D values after day 3 were
similar. In contrast to the rachitic children, control children did
not increase their 1,25(OH)2D concentrations in response to
vitamin D administration.
One child with rickets who received vitamin D3 was excluded
from analysis as an outlier because her response clearly differed
from all other children with rickets. She had a relatively low
baseline 1,25(OH)2D concentration (77pg/mL) and had no
change in 1,25(OH)2D (71pg/mL on day 3) despite an increase in
25(OH)D concentration from 32 to 69ng/mL after administration
of vitamin D3. Her biochemical profile was consistent with
hypophosphatemic rickets.
Serum 24,25(OH)2D showed an initial increase after vitamin D
administration (Fig. 4). In both rachitic and control children,
values of 24,25(OH)2D rose more rapidly, peaking earlier (day 3
compared with day 7) and declining more rapidly after
administration of vitamin D2 than after vitamin D3, suggesting
more rapid catabolism of 25(OH)D2 than 25(OH)D3 and a more
rapid clearance of 24,25(OH)2D2. The incremental areas under
the curve for 24,25(OH)2D were 26.1 13.0 and 28.6 18.6ng/
mL per day in rachitic children who received vitamins D2 and D3,
respectively (p¼.03). In control children, the incremental areas
under the curve for 24,25(OH)2D (41.0 20.6 and 65.0 27.8ng/
mL per day for the vitamin D2 and vitamin D3 groups,
respectively; p¼.04) were significantly greater than those of
rachitic children (p¼.002). In both groups of children with
rickets, total 24,25(OH)2D was highly correlated with total
25(OH)D at all time points (r¼0.84 to 0.96). In the two groups of
Fig. 1. Mean serum concentrations of 25(OH)D in response to oral
vitamin D2 or vitamin D3 administration (1.25mg) in children with
nutritional rickets and control children. Bars indicate standard error
of the mean, and asterisks denote p<.01 for comparison with
vitamin D3 group.
Fig. 2. Change in serum 25(OH)D3 after administration of oral vitamin D2
administration in healthy control children and in children with rickets.
Bars indicate standard error of the mean.
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correlation was less (r¼0.64 to 0.76). Figure 5 displays the
24,25(OH)2D concentrations as a proportion of 25(OH)D
concentrations, which were significantly greater at baseline in
control children (16% 6%) than in rachitic children (6% 3%,
p<.001), suggesting that the rachitic children converted a
greater proportion of 25(OH)D to 1,25(OH)2D than to
24,25(OH)2D prior to administration of vitamin D. After vitamin
D administration, all groups of children demonstrated an initial
fall in the proportion of 24,25(OH)2D on day 1 owing to the rapid
increase in 25(OH)D concentrations.
The increment in 1,25(OH)2D was unrelated to baseline
25(OH)D concentrations (r¼ 0.22, p¼.24). Unlike our previous
study, in which we demonstrated a positive relationship
between 1,25(OH)2D and 25(OH)D in children with rickets after
administration of vitamin D2, we found no significant correla-
tions at any time point between 1,25(OH)2D and 25(OH)D in
children with rickets after administration of vitamin D3. Similarly
in the control children, no significant relationships between
1,25(OH)2D and 25(OH)D were found after administration of
either vitamin D2 or vitamin D3.
Discussion
In the short term, vitamins D2 and D3 appear to produce similar
increases in 25(OH)D concentrations in both rachitic and healthy
children. The increment in 25(OH)D in response to a single oral
dose of 1.25mg of vitamin D2 or vitamin D3 was approximately
Fig. 3. Mean serum concentrations of 1,25(OH)2D in response to oral
vitamin D2 or vitamin D3 administration in children with nutritional
rickets and control children. Bars indicate standard error of the mean.
Fig. 4. Mean serum concentrations of 24,25(OH)2D in response to oral
vitamin D2 or vitamin D3 administration in children with nutritional
rickets and control children. Bars indicate standard error of the mean.
Fig. 5. Mean 24,25(OH)2D concentrations as a proportion of 25(OH)D
concentrations in response to oral vitamin D2 or vitamin D3 administra-
tion in children with nutritional rickets and control children. Bars indicate
standard error of the mean.
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children with rickets and in healthy control children. The peak
concentration of 25(OH)D that occurred 3 days after vitamin D
administrationisearlierthanthatseeninadults(7days).
(21,22) We
surmise that this may be related to a greater activity of hepatic
25-hydroxylase in children compared with adults. Indirect
evidence for this is the observation that older adults have a
less rapid rise and a slower clearance of 25(OH)D than younger
adults.
(21)
The serum concentration of 25(OH)D3 declined gradually after
administration of oral gradually D2 in both healthy control
children (33% reduction by day 14) and children with rickets
(50% reduction by day 14). In the children with rickets, this effect
could be due to both induction of CYP24 by increasing
concentrations of 1,25(OH)2D and competitive displacement
of 25(OH)D3 from vitamin D–binding protein by 25(OH)D2.
Because there was no significant increase in circulating
1,25(OH)2D after administration of vitamin D2 to normal children,
the decline in serum 25(OH)D3 in these children was likely due
solely to displacement from vitamin D–binding protein. We saw
no difference between the disappearance rate of 25(OH)D after
administration of vitamin D2 or vitamin D3 in the control groups,
which suggests that these two forms of vitamin D are
bioequivalent in normal healthy children. By contrast, in children
with rickets, there was a suggestion of a more rapid decline in
25(OH)D after vitamin D2 administration than after vitamin D3
administration. Because there were no differences in 1,25(OH)2D
generated after administration of vitamin D2 or vitamin D3,i ti s
likely that the more rapid disappearance of 25(OH)D after
vitamin D2 administration than after vitamin D3 administration is
due to a greater rate of catabolism of 25(OH)D2, either by CYP24
[baseline levels of 24,25(OH)2D and 24,25(OH)2D:25(OH)D ratios
were greater in the vitamin D2 group than in the vitamin D3
group] or by CYP3A4. Although it is possible that the greater
apparent rate of catabolism of 25(OH)D2 is due to intrinsic
differences between this metabolite and 25(OH)D3 as enzyme
substrates, we cannot exclude the contrasting possibility that
vitamin D clearance pathway(s) were more active in the children
who received vitamin D2, particularly because clinical rickets
seemed more severe in the vitamin D2 group than in the vitamin
D3 group.
Elevated 1,25(OH)2D concentrations prior to treatment and a
marked increase in 1,25(OH)2D concentrations in response to
vitamin D reliably distinguished children with putative dietary
calcium-deficiency rickets from healthy children and are
consistentwithfunctionalvitaminDdeficiencyand/orsecondary
hyperparathyroidism in children with calcium-deficiency rickets.
We confirmed that this increase in 1,25(OH)2D occurred in
response to both vitamin D3 and vitamin D2 administration. A
lack of response in 1,25(OH)2D concentrations to the adminis-
tration of vitamin D or 25(OH)D has been used to define vitamin
D sufficiency
(10); thus, by this definition, the rachitic children
would be defined as having vitamin D insufficiency. In children
with dietary calcium-deficiency rickets, high production rates of
1,25(OH)2D probably represent an exaggerated parathyroid
hormone (PTH)–mediated stimulation of 1a-hydroxylase owing
toinadequatecalcium intake.Ofnote, theincrease in1,25(OH)2D
concentration after vitamin D administration inNigerian children
with rickets does not produce a corresponding increase in
fractional calcium absorption
(20) probably because intestinal
calcium absorption (72%) is already maximal. We propose that
primary calcium deficiency in Nigerian children induces an
increase in 1a-hydroxylase activity that, combined with
increased activity of degradative pathways (eg, CYP24), results
in a state of relative vitamin D deficiency.
(12) Based on a growing
body of evidence, it is likely that reduced serum levels of
25(OH)D have an independent and adverse effect on bone and
mineral metabolism in these children, leading both to increased
secretion of PTH
(23,24) and impaired bone mineralization.
(25)
Despite their greater baseline 1,25(OH)2D concentrations,
rachitic children had lower baseline 24,25(OH)2D concentrations
than control children. 1,25(OH)2D is known to induce the
expression of CYP24A1, the 24-hydroxylase enzyme responsible
for catabolism of vitamin D.
(13) We had expected to find greater
24,25(OH)2D concentrations or increased ratios of
24,25(OH)2D3:25(OH)D in children with rickets than in control
children, consistent with induction of CYP24 by elevated
concentrations of 1,25(OH)2D.
(14) In fact, we found the opposite:
Children with rickets had lower ratios of 24,25(OH)2D:25(OH)D
than control subjects, similar to the changes in 24,25(OH)2D that
occur in children with nutritional rickets.
(1,26) These observations
do not necessarily refute the notion that low baseline levels of
25(OH)Dintherachiticchildrenareduetoincreaseddegradation
because 24,25(OH)2D and 25(OH)D may be processed to other
vitamin D metabolites or eliminated directly. However, we
cannot exclude insufficient supply of vitamin D (eg, inadequate
sunlightexposure)asacontributingfactor.Carefulanalysisofthe
clearance rate of 25(OH)D would be necessary to confirm the
increased rate of catabolism of 25(OH)D by CYP24 or other
pathways (eg, CYP3A4).
(27)
Some of our findings are consistent with more rapid
metabolism of vitamin D2 than vitamin D3. One day following
vitamin D administration, the concentration of serum vitamin D2
was lower in control children who received vitamin D2 than the
vitamin D3 concentration in control children who received
vitamin D3. At the same time, the 25(OH)D concentration rose
more rapidly (p¼.05 for difference in day 1 increment) and was
followed by an earlier decline in children with rickets who
received vitamin D2 compared with rachitic children who
received vitamin D3. In both children with rickets and control
children, the concentrations of 24,25(OH)2D rose more rapidly
and declined earlier after vitamin D2 administration than after
vitamin D3 administration. More rapid metabolism of vitamin D2
than vitamin D3 could reflect loweraffinity forvitamin D–binding
protein, increased affinity for the 24-hydroxylase CYP24 enzyme,
and/or increased affinity for the 1a-hydroxylase CYP27B1.
Our previous study of the response to vitamin D2 in Nigerian
children with rickets was limited by the absence of a control
group without rickets.
(12) This study thus offers several
advantages over our previous work. For example, the findings
of this study are strengthened by inclusion of control groups of
healthy children, and we were able to compare the responses to
vitamin D2 and vitamin D3. However, this report also has several
limitations. The children with rickets who received vitamin D2
were a historical comparison group that was studied with an
identical protocol. Consequently, their baseline characteristics
METABOLISM OF VITAMINS D2 AND D3 IN RICKETS Journal of Bone and Mineral Research 1993differed from rachitic children who received vitamin D3, and the
laboratory methods for determining vitamin D metabolites were
different. However, we were able to demonstrate on stored sera
the comparability of laboratory methods. We elected to use the
historical vitamin D2 group of children with rickets because
randomlyassigningthegroupwithricketsinthisstudytoreceive
either vitamin D2 or vitamin D3 would have resulted in only half
the number of children with rickets in each group, which would
haveresultedinreducedpowerinanalreadylimitedsamplesize.
By using the same methodology and the same laboratory, we
could compare the results directly without having to repeat the
vitamin D2 challenge in a group of children with rickets. An
additional shortcoming of this report includes the fact that the
rachitic children who received vitamin D2 appeared to be more
severely affected than the children who received vitamin D3.
Finally, the lack of information on PTH concentrations in any of
the groups of children makes our interpretation on the possible
differences in factors driving CYP27B1 speculative.
We conclude that in the short term, vitamins D2 and D3
similarly increase 25(OH)D concentrations in rachitic and healthy
children. However, vitamin D2 may be metabolized more rapidly
than vitamin D3, thus supporting previous recommendations
that cholecalciferol be considered the vitamin D of choice for the
treatment of rickets. A marked increase in 1,25(OH)2D
concentration in response to administration of vitamin D
distinguishes children with putative dietary calcium-deficiency
rickets from healthy children, thus indicating that vitamin D plus
calcium should be used together in the treatment of nutritional
rickets whether vitamin D or calcium deficiency is the primary
etiology.
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